ArticleJournal of Crohn's & colitis2020
Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience.
Article in Journal of Crohn's & colitis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 41 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.Annals of the rheumatic diseases · 2021Guideline
- The Impact of the COVID-19 Pandemic on Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey.Advances in therapy · 2024Article
- Prevention and control of coronavirus disease 2019 (COVID-19) in public places.Environmental pollution (Barking, Essex : 1987) · 2022Article
- Pathogenic perspective of missense mutations of ORF3a protein of SARS-CoV-2.Virus research · 2021Article
- How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician.World journal of gastroenterology · 2021Review
- Impact of COVID-19 outbreak on the care of patients with inflammatory bowel disease: A comparison before and after the outbreak in South China.Journal of gastroenterology and hepatology · 2021Observational
- Implications of COVID-19 for the busy gastroenterologist.European journal of gastroenterology & hepatology · 2021Review
- Practical Guidance for Dietary Management of Patients With Inflammatory Bowel Disease During the SARS-CoV2 Pandemic.Journal of the Academy of Nutrition and Dietetics · 2021Article
- What Do Influenza and COVID-19 Represent for Patients With Inflammatory Bowel Disease?Gastroenterology research · 2021Review
- Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2021Review
- COVID-19 detection using federated machine learning.PloS one · 2021Article
- Balancing Risks and Benefits in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic.Gastroenterology · 2021Article
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist.Digestive diseases (Basel, Switzerland) · 2021Review
- Implications of recurrent SARS-CoV-2 outbreaks for IBD management.Frontline gastroenterology · 2021Review
- Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.Frontiers in cellular and infection microbiology · 2021Review
- COVID-19 quarantine measures are associated with negative social impacts and compromised follow-up care in patients with inflammatory bowel disease in Brazil.Annals of gastroenterology · 2021Article
- Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care.United European gastroenterology journal · 2020Article
- Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease.Inflammatory bowel diseases · 2020Review
- Prevention and control of COVID-19 in nursing homes, orphanages, and prisons.Environmental pollution (Barking, Essex : 1987) · 2020Article
- Update on the neurology of COVID-19.Journal of medical virology · 2020Article
Corrections and comments
- Erratum issuedA Corrigendum.2021
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The outbreak of the COVID-19 caused by coronavirus SARS-CoV2, is rapidly spreading worldwide. This is the first pandemic caused by a coronavirus in history. More than 150 000 confirmed cases worldwide are reported involving the SARS-CoV2, with more than 5000 COVID-19-related deaths on March 14, 2020. Fever, chills, cough, shortness of breath, generalised myalgia, malaise, drowsiness, diarrhoea, confusion, dyspnoea, and bilateral interstitial pneumonia are the common symptoms. No therapies are available, and the only way to contain the virus spread is to regularly and thoroughly clean one's hands with an alcohol-based hand rub or wash them with soap and water, to maintain at least 1 m [3 feet] distance from anyone who is coughing or sneezing, to avoid touching eyes, nose, and mouth, and to stay home if one feels unwell. No data are available on the risk of COVID-19 and outcomes in inflammatory bowel disease [IBD] patients. Outbreak restrictions can impact on the IBD care. We aim to give a viewpoint on how operationally to manage IBD patients and ensure quality of care in the current pandemic era.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.